| CXHL2500488 | QLM2012 | | | Chemical Drugs(2.2) | New Drug Application | 2025-05-19 | | QILU Pharmaceutical Co Ltd | | | view |
| CXHL2500489 | QLM2012 | | | Chemical Drugs(2.2) | New Drug Application | 2025-05-19 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSB2500066 | QL2108注射液 | QL-2108 | Injection | Biological Products | Supplementary Application | 2025-05-14 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSB2500064 | QL2108注射液 | QL-2108 | Injection | Biological Products | Supplementary Application | 2025-05-14 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSB2500065 | QL2108注射液 | QL-2108 | Injection | Biological Products | Supplementary Application | 2025-05-14 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSB2500063 | QL2108注射液 | QL-2108 | Injection | Biological Products | Supplementary Application | 2025-05-14 | | QILU Pharmaceutical Co Ltd | | | view |
| CYSB2500104 | 艾帕洛利托沃瑞利单抗注射液 | iparomlimab;tuvonralimab | Injection | Biological Products | Supplementary Application | 2025-05-14 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSL2500326 | 注射用QLS5133 | | Lyophilized | Biological Products(1) | New Drug Application | 2025-04-23 | | QILU Pharmaceutical Co Ltd | | | view |
| CYHS2501524 | 磷酸芦可替尼片 | ruxolitinib phosphate | Tablet | Chemical Drugs(4) | Generic Drug | 2025-04-22 | | QILU Pharmaceutical Co Ltd | | | view |
| CYHS2501525 | 磷酸芦可替尼片 | ruxolitinib phosphate | Tablet | Chemical Drugs(4) | Generic Drug | 2025-04-22 | | QILU Pharmaceutical Co Ltd | | | view |
| CYHS2501523 | 磷酸芦可替尼片 | ruxolitinib phosphate | Tablet | Chemical Drugs(4) | Generic Drug | 2025-04-22 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSL2500285 | 注射用QLS32015 | QLS-32015 | Lyophilized | Biological Products(1) | New Drug Application | 2025-04-10 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSL2500284 | QL2109注射液 | QL-2109 | Injection | Biological Products(2.2) | New Drug Application | 2025-04-10 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSB2500045 | QL2111注射液 | QL-2111 | Injection | Biological Products | Supplementary Application | 2025-04-03 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSB2500046 | QL2111注射液 | QL-2111 | Injection | Biological Products | Supplementary Application | 2025-04-03 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSB2500036 | 注射用QLS32015 | QLS-32015 | Lyophilized | Biological Products | Supplementary Application | 2025-03-18 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSB2500034 | 注射用QLS32015 | QLS-32015 | Lyophilized | Biological Products | Supplementary Application | 2025-03-18 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSB2500035 | 注射用QLS32015 | QLS-32015 | Lyophilized | Biological Products | Supplementary Application | 2025-03-18 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSL2500217 | QL2107注射液 | pembrolizumab | Injection | Biological Products(2.2) | New Drug Application | 2025-03-11 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSL2500218 | 帕尼单抗注射液 | panitumumab | Other | Biological Products(2.2) | New Drug Application | 2025-03-11 | | QILU Pharmaceutical Co Ltd | | | view |
